Details for Patent: 8,155,737
✉ Email this page to a colleague
Which drugs does patent 8,155,737 protect, and when does it expire?
Patent 8,155,737 protects ZECUITY and is included in one NDA.
This patent has sixteen patent family members in eleven countries.
Summary for Patent: 8,155,737
| Title: | Pharmacokinetics of iontophoretic sumatriptan administration |
| Abstract: | Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described. |
| Inventor(s): | Sebree; Terri B. (Gladwyne, PA), Pierce; Mark (Essex, CT), O'Neill; Carol (Conshohocken, PA) |
| Assignee: | NuPathe, Inc. (Conshohocken, PA) |
| Application Number: | 12/142,604 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,155,737
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | ZECUITY | sumatriptan succinate | SYSTEM;IONTOPHORESIS | 202278-001 | Jan 17, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | METHOD FOR TREATING ACUTE MIGRAINE IN ADULTS, WITH OR WITHOUT AURA,COMPRISING IONTOPHORETIC TRANSDERMAL DELIVERY OF SUMATRIPTAN OR A SALT THEREOF | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,155,737
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008358027 | ⤷ Sign Up | |||
| Australia | 2015238858 | ⤷ Sign Up | |||
| Canada | 2727927 | ⤷ Sign Up | |||
| Eurasian Patent Organization | 025505 | ⤷ Sign Up | |||
| Eurasian Patent Organization | 201100056 | ⤷ Sign Up | |||
| European Patent Office | 2303392 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
